%0 Journal Article %A Maxwell A. Weinzierl %A Suellen Hopfer %A Sanda M. Harabagiu %T Scaling Up the Discovery of Hesitancy Profiles by Identifying the Framing of Beliefs towards Vaccine Confidence in Twitter Discourse %D 2021 %R 10.1101/2021.10.01.21264439 %J medRxiv %P 2021.10.01.21264439 %X Our study focused on the inference of the framing of confidence in the HPV vaccine throughout a collection of 422,078 tweets as well as the framing of confidence in the COVID-19 vaccines through a collection of 5,865,046 tweets. The vaccine confidence framings were inferred by using a novel Question/Answering framework enabling the derivation of a misinformation taxonomy as well as trust taxonomies for these two vaccines. These taxonomies, along with the analysis of vaccine literacy, the implied moral foundations and the tension between vaccine mandates and civil rights allowed us to discover several profiles of hesitancy for each vaccine across 138,779 Twitter users referring to confidence in HPV vaccine and 665,798 users referring to confidence in COVID-19 vaccines. These hesitancy profiles inform public health messaging approaches to effectively reach Twitter users with promise to shift or bolster vaccine attitudes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIRB-21-515Funding StatementThe authors did not receive support from any organization for the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by The University of Texas at Dallas Institutional Review Board (IRB-21-515 stipulated that our research met the criteria for exemption #8(iii) of the Chapter 45 of Federal Regulations Part 46.101.(b)).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTwitter forbids the release of raw twitter data, but annotations and taxonomies will be released upon acceptance. %U https://www.medrxiv.org/content/medrxiv/early/2021/10/06/2021.10.01.21264439.full.pdf